Tran, Kim TuMcMenamin, Úna C.Hicks, BlánaidMurchie, PeterThrift, Aaron P.Coleman, Helen G.Iversen, LisaJohnston, Brian T.Lee, Amanda J.Cardwell, Chris R.2019-05-082019-05-082018-07Tran, K T, McMenamin, Ú C, Hicks, B, Murchie, P, Thrift, A P, Coleman, H G, Iversen, L, Johnston, B T, Lee, A J & Cardwell, C R 2018, 'Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies', Alimentary Pharmacology & Therapeutics, vol. 48, no. 1, pp. 55-64. https://doi.org/10.1111/apt.147960269-2813ORCID: /0000-0001-9968-5991/work/83704281ORCID: /0000-0002-4865-9061/work/159078228http://hdl.handle.net/2164/12243The analysis of UK Biobank has been conducted using the UK Biobank Resource under Application Number 34374. We acknowledge collaboration with the Research Applications and Data Management Team lead by Ms Katie Wilde, University of Aberdeen in conducting this study. KTT is supported by the Vietnam International Education Cooperation Department. Access to PCCIU data was provided by Queen’s University Belfast and the Centre for Academic Primary Care, University of Aberdeen. Access to the UK Biobank was funded by a Cancer Research UK Population Research Postdoctoral Fellowship awarded to ÚCMcM. HGC is a co-investigator of the UKCRC Centre of Excellence for Public Health Northern Ireland.10760008engSDG 3 - Good Health and Well-beingRC0254 Neoplasms. Tumors. Oncology (including Cancer)Cancer Research UKRC0254Journal article10.1111/apt.14796481